Development and validation of the UHPLC-MS/MS method for the quantitative determination of 25 PFAS in dried blood spots
Analytical and Bioanalytical Chemistry · 2024
DOI: 10.1007/s00216-024-05484-6 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Analytical and Bioanalytical Chemistry, 2024. Verfasst von Martina Galletto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Turin, Turin, Italy. martina.galletto@unito.it. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Dried Blood Spot Testing, Fluorocarbons, Limit of Detection. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Torino.
Abstract (Originalsprache)
Per- and polyfluoroalkyl substances (PFAS) are anthropogenic fluorine-containing compounds largely used in industrial and consumer applications. They tend to bioaccumulate in the human body after intake from various sources in daily life. Following repeated exposure to PFAS, a broad range of adverse health outcomes has been reported. Consequently, monitoring PFAS levels in human blood is of paramount importance for public health policies. In contrast with traditional venipuncture, dried blood spots (DBS) constitute a reliable, cheap, and less invasive technique to allow microsampling by capillary blood collected on a specific device. This work aimed to develop and validate an innovative analytical method, combining quantitative DBS with UHPLC-MS/MS instrumentation to identify and quantify 25 PFAS. The extraction procedure was developed and optimized within the range 2–100 ng/mL. Specifically, fortified blood was applied on Capitainer ® B devices providing 10 μL of blood volume through a microfluidic channel. After 3 h of drying, the extraction was performed by methanol under sonication, followed by centrifugation. Then, the extraction solvent was evaporated; the residue was reconstituted with the mobile phase solution. The validated method evidenced good sensitivity, with limits of detection ranging from 0.4 ng/mL (PFODA, PFOS) to 1.0 ng/mL (PFOA, 3,6-OPFHpA). The ± 20% acceptability criteria established for intra- and inter-day precision and accuracy were fulfilled for all analytes. High recovery—above 80%—was recorded, whereas significant matrix effect resulted in ion enhancement (> 50%) for 13 analytes. In conclusion, the proposed workflow proved to be reliable, fit for purpose, and easily adaptable in the laboratory routine. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Turin, Turin, Italy. martina.galletto@unito.it.
- Department of Chemistry, University of Turin, Turin, Italy.
- Centro Regionale Antidoping, Orbassano, TO, Italy.
Förderung
- Università degli Studi di Torino
Zitieren
APA
Galletto, M., Ververi, C., Massano, M., Alladio, E., Vincenti, M., & Salomone, A. (2024). Development and validation of the UHPLC-MS/MS method for the quantitative determination of 25 PFAS in dried blood spots. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-024-05484-6
Vancouver
Galletto M, Ververi C, Massano M, Alladio E, Vincenti M, Salomone A. Development and validation of the UHPLC-MS/MS method for the quantitative determination of 25 PFAS in dried blood spots. Analytical and Bioanalytical Chemistry. 2024. doi:10.1007/s00216-024-05484-6
BibTeX
@article{Galletto2024,
author = {Galletto, Martina and Ververi, Christina and Massano, Marta and Alladio, Eugenio and Vincenti, Marco and Salomone, Alberto},
title = {Development and validation of the UHPLC-MS/MS method for the quantitative determination of 25 PFAS in dried blood spots},
journal = {Analytical and Bioanalytical Chemistry},
year = {2024},
doi = {10.1007/s00216-024-05484-6}
}
EUVIMED